Schedule 13D ownership disclosure
Edge Therapeutics, Inc.
Security class unavailable · CUSIP: 279870109
Event date: 2019-03-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-19-016355
- Form type
- SC 13D
- Filer
- PDS Biotechnology Corp
- CIK
- CIK 1472091
- Filed
- Mar 28, 2019
- Reporting period
- Mar 15, 2019
- Description
- Schedule 13D beneficial ownership